MetaCap

Smith & Nephew SNATS (SNN) vs STERIS (Ireland) (STE)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

STERIS (Ireland) (STE) has outperformed Smith & Nephew SNATS (SNN) over the past year, losing 2.9% versus a loss of 9.6%. Over five years, STE leads with a +12.5% price change compared with -9.2% for SNN. STERIS (Ireland) is the larger company by market cap ($24.84 billion vs $12.47 billion), about 2.0 times the size.

On valuation, Smith & Nephew SNATS trades at a lower forward P/E (12.6x vs 20.5x for STERIS (Ireland)). Smith & Nephew SNATS offers the higher dividend yield (1.33% vs 1.01%). STERIS (Ireland) converts more of its revenue into profit, with a net margin of 13.2% versus 10.1%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

SNN-9.58%STE-2.86%
+14%-6%-26%
Nov 21, 20251 yearNov 20, 2026
SNN-13.86%STE+9.51%
+18%-11%-40%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

SNN versus STE key metrics
MetricSNNSTE
Share price$29.83$255.76
Market cap$12.47B$24.84B
1-day change0.00%+0.39%
YTD return-9.08%+0.88%
1-year return-9.58%-2.86%
5-year return-9.19%+12.52%
P/E ratio (TTM)20.2930.34
Forward P/E12.5720.53
EPS (TTM)$1.47$8.43
Dividend yield1.33%1.01%
Annual dividend$0.397$2.58
Revenue (latest FY)$6.16B$5.94B
Revenue growth (YoY)+6.09%+8.73%
Net income (latest FY)$625.00M$782.30M
Gross margin68.01%44.25%
Operating margin12.88%18.56%
Net margin10.14%13.18%
52-week high$37.09$269.44
52-week low$26.12$195.14
Distance from 52-week high-19.57%-5.08%
Analyst consensusholdbuy
Avg. price target upside+11.26%+9.92%
Average volume1.55M735.68K
Shares outstanding418.11M97.11M
Employees17,00017,937
SectorHealth CareHealth Care
IndustryIndustrial SpecialtiesIndustrial Specialties

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • STERIS (Ireland) trades at a higher earnings multiple (30.3x vs 20.3x trailing P/E).

About Smith & Nephew SNATS

SNN stock →

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management.

Health Care · Industrial Specialties · 17,000 employees

About STERIS (Ireland)

STE stock →

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences.

Health Care · Industrial Specialties · 17,937 employees

SNN vs STE FAQ

Which is bigger, Smith & Nephew SNATS or STERIS (Ireland)?

STERIS (Ireland) (STE) is larger, with a market capitalization of $24.84B compared with $12.47B for Smith & Nephew SNATS (SNN).

Which stock has performed better over the past year, SNN or STE?

STE returned -2.86% over the past 12 months, compared with -9.58% for SNN (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, SNN or STE?

SNN has the lower trailing P/E at 20.3, versus 30.3 for STE. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Smith & Nephew SNATS or STERIS (Ireland)?

Smith & Nephew SNATS has the higher yield at 1.33%, compared with 1.01% for STERIS (Ireland).

Are Smith & Nephew SNATS and STERIS (Ireland) in the same industry?

Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.

More comparisons